- Home
- CRT vs ANL Comparison
CRT vs ANL Comparison
Compare CRT & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- ANL
- Stock Information
- Founded
- CRT 1991
- ANL 2004
- Country
- CRT United States
- ANL Cayman Islands
- Employees
- CRT N/A
- ANL N/A
- Industry
- CRT Oil & Gas Production
- ANL
- Sector
- CRT Energy
- ANL
- Exchange
- CRT Nasdaq
- ANL Nasdaq
- Market Cap
- CRT 65.1M
- ANL 56.0M
- IPO Year
- CRT 1992
- ANL 2023
- Fundamental
- Price
- CRT $9.58
- ANL $1.42
- Analyst Decision
- CRT
- ANL Hold
- Analyst Count
- CRT 0
- ANL 1
- Target Price
- CRT N/A
- ANL N/A
- AVG Volume (30 Days)
- CRT 19.2K
- ANL 6.1K
- Earning Date
- CRT 01-01-0001
- ANL 08-08-2025
- Dividend Yield
- CRT 9.32%
- ANL N/A
- EPS Growth
- CRT N/A
- ANL N/A
- EPS
- CRT 0.99
- ANL N/A
- Revenue
- CRT $6,834,116.00
- ANL N/A
- Revenue This Year
- CRT N/A
- ANL N/A
- Revenue Next Year
- CRT N/A
- ANL N/A
- P/E Ratio
- CRT $9.58
- ANL N/A
- Revenue Growth
- CRT N/A
- ANL N/A
- 52 Week Low
- CRT $8.88
- ANL $1.10
- 52 Week High
- CRT $13.31
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- CRT 42.09
- ANL 40.84
- Support Level
- CRT $9.49
- ANL $1.48
- Resistance Level
- CRT $9.86
- ANL $1.55
- Average True Range (ATR)
- CRT 0.13
- ANL 0.05
- MACD
- CRT -0.01
- ANL -0.00
- Stochastic Oscillator
- CRT 37.78
- ANL 2.27
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.